Katrien Van Roosbroeck

2.8k total citations
21 papers, 1.3k citations indexed

About

Katrien Van Roosbroeck is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, Katrien Van Roosbroeck has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 10 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in Katrien Van Roosbroeck's work include Chronic Lymphocytic Leukemia Research (9 papers), MicroRNA in disease regulation (9 papers) and Lymphoma Diagnosis and Treatment (8 papers). Katrien Van Roosbroeck is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), MicroRNA in disease regulation (9 papers) and Lymphoma Diagnosis and Treatment (8 papers). Katrien Van Roosbroeck collaborates with scholars based in United States, Belgium and Germany. Katrien Van Roosbroeck's co-authors include George A. Călin, Recep Bayraktar, Jeroen Pollet, Iwona Włodarska, Peter Vandenberghe, Jan Cools, Chris De Wolf‐Peeters, Daan Dierickx, Idoya Lahortiga and Peter Marynen and has published in prestigious journals such as Nature Genetics, Blood and PLoS ONE.

In The Last Decade

Katrien Van Roosbroeck

20 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katrien Van Roosbroeck United States 14 852 695 272 242 176 21 1.3k
Lenka Sedlaříková Czechia 13 616 0.7× 289 0.4× 277 1.0× 130 0.5× 115 0.7× 33 1.0k
Vanessa J. Craig United States 12 441 0.5× 244 0.4× 149 0.5× 182 0.8× 76 0.4× 17 1.1k
Paul Takam Kamga Italy 16 610 0.7× 320 0.5× 224 0.8× 40 0.2× 297 1.7× 34 966
Rédouane Rouas Belgium 16 577 0.7× 491 0.7× 195 0.7× 46 0.2× 266 1.5× 26 1.3k
Sheila N.J. Sait United States 20 510 0.6× 192 0.3× 334 1.2× 178 0.7× 206 1.2× 72 1.2k
Valeria Zuccalà Italy 20 548 0.6× 257 0.4× 210 0.8× 59 0.2× 106 0.6× 55 1.1k
Beena Pushkaran United Kingdom 5 1.3k 1.5× 1.3k 1.8× 75 0.3× 75 0.3× 83 0.5× 6 1.6k
Motozo Yamashita Japan 16 1.1k 1.3× 248 0.4× 382 1.4× 69 0.3× 50 0.3× 20 1.6k
Cecilia Fernandez-Cymering United States 5 1.9k 2.2× 1.6k 2.3× 106 0.4× 51 0.2× 84 0.5× 6 2.2k
Damiano Fantini United States 17 871 1.0× 173 0.2× 275 1.0× 87 0.4× 34 0.2× 27 1.2k

Countries citing papers authored by Katrien Van Roosbroeck

Since Specialization
Citations

This map shows the geographic impact of Katrien Van Roosbroeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrien Van Roosbroeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrien Van Roosbroeck more than expected).

Fields of papers citing papers by Katrien Van Roosbroeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrien Van Roosbroeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrien Van Roosbroeck. The network helps show where Katrien Van Roosbroeck may publish in the future.

Co-authorship network of co-authors of Katrien Van Roosbroeck

This figure shows the co-authorship network connecting the top 25 collaborators of Katrien Van Roosbroeck. A scholar is included among the top collaborators of Katrien Van Roosbroeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrien Van Roosbroeck. Katrien Van Roosbroeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Esposito, Carla Lucia, Katrien Van Roosbroeck, Gianluca Santamaria, et al.. (2021). Selection of a Nuclease-Resistant RNA Aptamer Targeting CD19. Cancers. 13(20). 5220–5220. 9 indexed citations
2.
Roosbroeck, Katrien Van, Recep Bayraktar, Steliana Calin, et al.. (2018). The involvement of microRNA in the pathogenesis of Richter syndrome. Haematologica. 104(5). 1004–1015. 16 indexed citations
3.
Roosbroeck, Katrien Van, Recep Bayraktar, & George A. Călin. (2018). Measurement of miRNAs in Chronic Lymphocytic Leukemia Patient Samples by Quantitative Reverse Transcription PCR. Methods in molecular biology. 1881. 267–276.
4.
Roosbroeck, Katrien Van & George A. Călin. (2017). Cancer Hallmarks and MicroRNAs: The Therapeutic Connection. Advances in cancer research. 135. 119–149. 129 indexed citations
5.
Bayraktar, Recep & Katrien Van Roosbroeck. (2017). miR-155 in cancer drug resistance and as target for miRNA-based therapeutics. Cancer and Metastasis Reviews. 37(1). 33–44. 186 indexed citations
6.
Bayraktar, Recep, Katrien Van Roosbroeck, & George A. Călin. (2017). Cell‐to‐cell communication: microRNAs as hormones. Molecular Oncology. 11(12). 1673–1686. 268 indexed citations
7.
Vitale, Candida, Lorenzo Falchi, Elisa ten Hacken, et al.. (2016). Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics. Clinical Cancer Research. 22(10). 2359–2367. 23 indexed citations
8.
Roosbroeck, Katrien Van & George A. Călin. (2016). MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?. Seminars in Oncology. 43(2). 209–214. 26 indexed citations
9.
Roosbroeck, Katrien Van, José Luis Ferreiro, Thomas Tousseyn, et al.. (2016). Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignancies. Genes Chromosomes and Cancer. 55(5). 428–441. 37 indexed citations
10.
Roosbroeck, Katrien Van, Francesca Fanini, Tetsuro Setoyama, et al.. (2016). Targeting miR-155 to resensitize lung cancer to chemotherapy. European Journal of Cancer. 61. S116–S116. 2 indexed citations
11.
Hudson, Robert, Ming Yi, Natalia Volfovsky, et al.. (2013). Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Molecular Cancer. 12(1). 13–13. 51 indexed citations
12.
Nouraee, Nazila, Katrien Van Roosbroeck, Mohammad Vasei, et al.. (2013). Expression, Tissue Distribution and Function of miR-21 in Esophageal Squamous Cell Carcinoma. PLoS ONE. 8(9). e73009–e73009. 90 indexed citations
13.
Roosbroeck, Katrien Van, Jeroen Pollet, & George A. Călin. (2013). miRNAs and long noncoding RNAs as biomarkers in human diseases. Expert Review of Molecular Diagnostics. 13(2). 183–204. 118 indexed citations
14.
Roosbroeck, Katrien Van, Luk Cox, Thomas Tousseyn, et al.. (2011). JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma. Blood. 117(15). 4056–4064. 77 indexed citations
15.
Kleppe, Maria, Idoya Lahortiga, Kim De Keersmaecker, et al.. (2010). Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia. Nature Genetics. 42(6). 530–535. 141 indexed citations
16.
Roosbroeck, Katrien Van, Jan Cools, Daan Dierickx, et al.. (2010). ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions. Haematologica. 95(3). 509–513. 66 indexed citations
17.
Roosbroeck, Katrien Van, Luk Cox, Idoya Lahortiga, et al.. (2009). JAK2 Rearrangements, Including the Novel SEC31A-JAK2 Fusion, Are Recurrent in Classical Hodgkin Lymphoma.. Blood. 114(22). 140–140. 11 indexed citations
18.
Roosbroeck, Katrien Van, et al.. (2009). Oncogenic Anaplastic Lymphoma Kinase Rearrangements in Lymphoma. European Oncology & Haematology. 3(1). 50–50. 1 indexed citations
19.
Roosbroeck, Katrien Van, Idoya Lahortiga, Jan Cools, et al.. (2008). A novel t(4;9)(q21;p24) fuses SEC31A to JAK2 in nodular-sclerosis Hodgkin lymphoma. Haematologica. 92. 245–245. 2 indexed citations
20.
Roosbroeck, Katrien Van, Idoya Lahortiga, Peter Vandenberghe, et al.. (2007). New 9p24 abnormalities in hematological malignancies. Acta Clinica Belgica. 62(4). 260–260. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lenka Sedlaříková Breakdown of academic impact, for papers by Vanessa J. Craig Breakdown of academic impact, for papers by Paul Takam Kamga Breakdown of academic impact, for papers by Rédouane Rouas Breakdown of academic impact, for papers by Sheila N.J. Sait Breakdown of academic impact, for papers by Valeria Zuccalà Breakdown of academic impact, for papers by Beena Pushkaran Breakdown of academic impact, for papers by Motozo Yamashita Breakdown of academic impact, for papers by Cecilia Fernandez-Cymering Breakdown of academic impact, for papers by Damiano Fantini
Rankless by CCL
2026